GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster semaglutide-based weight‑loss injection—to Hims & Hers' digital storefront. The ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

But taking them abroad isn’t always simple. From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication. Medicines that are legal in the UK can be ...

New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...